111, Inc.
Based in Shanghai, People's Republic of China, 111, Inc. (established in 2010 and formerly known as New Peak Group until April 2018) is a prominent entity in the Chinese healthcare sector, operating a comprehensive online-to-offline (O2O) ecosystem. Its operations are structured across both business-to-business (B2B)…
1D
+1.3%
1W
-0.6%
1M
-7.4%
6M
-53.5%
YTD
+22.3%
1Y
-28.9%
2Y
-62.7%
5Y
-94.5%
10Y
–
Next earnings date
26/11/2026 (in 40 days)
Volatility around earnings
~47% stronger price swings than usual
P/E
-1.76
P/B
-1.61
EV/EBITDA
-4.99
RETURN ON EQUITY
34.2%
NET MARGIN
-1.7%
DEBT/EQUITY
-2.46
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
FREE FLOAT
98.2%
FLOAT SHARES
8,611,476
AVG. DAILY VOLUME (30D)
16,935
Chen Yang Luke
Chen Yang Luke
Chen Yang Luke
Chen Yang Luke
Chen Yang Luke
111, Inc. is a company in the Healthcare sector, Medical - Distribution industry, headquartered in China.
The CEO is Junling Liu, the company employs around 1,063 people.
The IPO was on 12/09/2018; the stock trades on NASDAQ under the ticker YI.
The next earnings date is 26/11/2026.
Around past earnings, price swings were roughly 47% stronger than usual.
No, 111 currently does not pay a dividend.
Comparable stocks include McKesson, Cencora, Cardinal Health, Henry Schein, DocMorris, Eli Lilly and Company, Johnson & Johnson and AbbVie.
Clicking "Analyze stock" lets five strategies assess 111 against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.